<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02339987</url>
  </required_header>
  <id_info>
    <org_study_id>TIL-PROCURE-0614</org_study_id>
    <nct_id>NCT02339987</nct_id>
  </id_info>
  <brief_title>Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration</brief_title>
  <official_title>Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>John Wayne Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>John Wayne Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to allow the collection of tissue from subjects to be used in
      future research studies by scientists and to isolate tumor fighting cells for the future
      treatment of Melanoma.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2014</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate Feasibility of conducting TIL procurement in a single-site setting</measure>
    <time_frame>5 years</time_frame>
    <description>Cell viability, viable number and TIL potency using standardized methods</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate Safety of conducting TIL procurement in a single-site setting</measure>
    <time_frame>5 separate TIL procedures</time_frame>
    <description>lab personnel training during procurement, isolation, testing tumor reactivity and cryopreservation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine whether TIL Procurement, isolation, testing tumor reactivity and cryopreservation can be performed at John Wayne Cancer Institute (JWCI) and Providence Saint John's Health Center (PSJHC) and infused into patients</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Melanoma</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tissue from resection of a metastatic melanoma lesion
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        cancer clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients must have metastatic melanoma with a resectable metastasis who are undergoing
             resection for palliation, therapeutic or curative purpose.

          2. Patients must be &gt; 15 years of age and must have metastatic melanoma.

          3. Patients must meet standard pre-operative requirements as determined by the surgeon to
             be candidates for surgery.

          4. Patients must be able to understand and sign the Informed Consent document.

          5. Patients must be able to complete the supplemental data form

        Exclusion Criteria:

          1. women who are pregnant or breastfeeding

          2. inability to give consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Santosh Kesari, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>John Wayne Cancer Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Santosh B. Kesari, MD, PhD</last_name>
    <phone>310-829-8265</phone>
    <email>KesariS@jwci.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kelly Garver</last_name>
    <phone>310-582-7456</phone>
    <email>garverk@jwci.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>John Wayne Cancer Institute</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly P Garver</last_name>
      <phone>310-582-7456</phone>
      <email>garverk@jwci.org</email>
    </contact>
    <investigator>
      <last_name>Mark B. Faries, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2015</study_first_submitted>
  <study_first_submitted_qc>January 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2015</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

